NCT06330051Completed
The Improve Acute Reperfusion Treatment Quality for Ischemic Stroke Through Spatiotemporal Computing Thecnology in China
The Improve Acute Reperfusion Treatment Quality for Ischemic Stroke Through Spatiotemporal Computing Technology in China (IMPROVE-II ) -A Multicenter Cluster-Randomized Controlled Study
Source: ClinicalTrials.gov · Last updated 29 Jun 2026
Brief summary (registry, in English)
This study intends to construct the goal-oriented integrated intervention model through the intelligent bracelet automatic positioning and feedback system based spatiotemporal computing technology (FAST model) to promote the reconstruction of workflow in stroke centers and to shorten in-hospital delay of reperfusion treatment for AIS patients. This is a multicenter, cluster-randomized controlled study aims to verify the efficacy and safety of the FAST model.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 2219 (actual)
- First submitted
- 19 Mar 2024
- Start date
- 18 Mar 2024
- Primary completion date
- 13 Oct 2025
- Lead sponsor
- Beijing Tiantan Hospital
- Diseases
- Stroke
- NCT number
- NCT06330051
What you commit to
- Study type: Interventional
- Participants enrolled: 2219
- From 18 Mar 2024 to the primary completion date, 13 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients refuse to sign informed consent and follow up until 3 months after stroke onset.
- Patients with mild nondisabling stroke (Defined as no measurable neurologic deficit, or NIHSS≤3 with only one of the following isolated symptoms: isolated facial paralysis; mild cortical blindness; mild hemianesthesia; mild hemiataxia.)
Other
- Hospitals#
- Hospital that unable to cooperate and complete the research.
- Hospitals that are participating in other AIS medical quality improvement projects or related clinical trials.
- Patients#
- Life expectancy three-months or less by judgment of the investigator.
- Participation in any interventional study that may affect the outcome
Who the study is looking for
- Hospitals#
- Secondary or tertiary public hospitals with an emergency department that receive patients with AIS.
- Admit at least 50 patients of AIS within 4.5 hours after onset each month.
- Have the capacity of intravenous thrombolytic therapy or/and endovascular treatment.
- Voluntarily participate in this research and cooperate with the installation of bluetooth positioning device and the improvement of AIS emergency procedures.
- Have good cooperation relationship among the department of Neurology, Emergency, Interventional department, Neurosurgery department, Laboratory department and Radiology department.
- Have ability to establish or participate in the establishment of patient information database and arrange a person responsible for the collection of case information.
- Patients# Patients who are ≥18 years old are eligible for inclusion if they present with AIS diagnosed by CT and/or MRI, arrive at hospital within 4.5 hours after symptom onset, sign the informed consent form and agree to follow up until 3 months after stroke onset.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| WuQing People's Hospital Coordinator of this site? Confirm its status | Tianjin | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.